ClassID:

242709

Y10S514/946 - CPC Classification

Classification description:

Sub-classes:
Recent Application in this class:
#1
20170119700
2017-05-04

Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages

#2
20150017234
2015-01-15

Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages

#3
20130316996
2013-11-28

Transdermal delivery rate control using amorphous pharmaceutical compositions

#4
20120225779
2012-09-06

PESTICIDAL COMPOSITIONS

#5
20120087974
2012-04-12

Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages

#6
20110281727
2011-11-17

Insecticidal and/or herbicidal composition having improved activity based on spiroheterocyclically substituted tetramic acid derivatives

#7
20110257141
2011-10-20

Transdermal testosterone formulation for minimizing skin residues

#8
20110110869
2011-05-12

STABLE HYDROALCOHOLIC COMPOSITIONS

#9
20110077296
2011-03-31

Method and composition for delivering zinc to the nasal membrane

#10
20110059141
2011-03-10

PERCUTANEOUS ABSORPTION PREPARATIONS OF ANTIDEMENTIA DRUGS

#11
20110038953
2011-02-17

Strontium compound for treatment of sub-dermal soft tissue pain

#12
20100323888
2010-12-23

Compositions and kits comprising a fungicidal triazole and an alkoxylated alcohol, and their uses

#13
20100317737
2010-12-16

TOPICAL DELIVERY OF L-ARGININE TO CAUSE BENEFICIAL EFFECTS

#14
20100316749
2010-12-16

TOPICAL DELIVERY OF L-ARGININE TO CAUSE BENEFICIAL EFFECTS

#15
20100209370
2010-08-19

Skin treatment composition

#16
20100166674
2010-07-01

TRANSDERMAL DELIVERY RATE CONTROL USING AMORPHOUS PHARMACEUTICAL COMPOSITIONS

#17
20100041718
2010-02-18

Pesticidal compositions

#18
20090069364
2009-03-12

PHARMACEUTICAL COMPOSITIONS OF 5-ALPHA-REDUCTASE INHIBITORS AND METHODS OF USE THEREOF

#19
20080293703
2008-11-27

Topical preparation and method for transdermal delivery and localization of therapeutic agents

#20
20080228152
2008-09-18

Treatment brassiere and method of producing same

#21
20080188568
2008-08-07

Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages

#22
20070270503
2007-11-22

Penetration of active substances into cells and organs

#23
20070265337
2007-11-15

METHOD AND COMPOSITION FOR DELIVERING ZINC TO THE NASAL MEMBRANE

#24
20070259028
2007-11-08

Percutaneous absorption preparations of antidementia drugs

#25
20070237836
2007-10-11

Strontium compound for treatment of sub-dermal soft tissue pain

#26
20070134308
2007-06-14

Non-steroidal anti-inflammatory drug formulations for topical applications to the skin

#27
20070128287
2007-06-07

Dermal composition for external use

#28
20060153905
2006-07-13

Transdermal pharmaceutical formulation for minimizing skin residues

#29
20050256200
2005-11-17

Benzoyl peroxide compositions having increased potency

#30
20050239724
2005-10-27

Skin penetration enhancing components

#31
20050229935
2005-10-20

Treatment brassiere and method of producing same

#32
20050220719
2005-10-06

Nasal passage cleaning composition

#33
20050175680
2005-08-11

Transdermal delivery rate control using amorphous pharmaceutical compositions

#34
20050124743
2005-06-09

Hybrid system for solubilizing pharmaceutically active substances in polymer matrices

#35
20050118243
2005-06-02

Method and composition for delivering zinc to the nasal membrane

#36
20050037060
2005-02-17

Pharmaceutical composition

#37
20050013877
2005-01-20

Strontium compound for treatment of sub-dermal soft tissue pain